CCND1 and liver cancer: (34), found that HBXIP can upregulate the expression of cyclin-D1 and cyclin-E in normal L-02liver cells, H7402 liver cancer cells, and MCF-7 breast cancer cells, and inhibit the expression of P21 and P27, which induce the G1/S-phase cell cycle transition.